Aclarion Inc

Health Information Services

Prices are adjusted according to historical splits.

Aclarion Inc Stock Price


Today's Low:
Today's High:
Open Price:
52W Low:
52W High:
Prev. Close:

Company Statistics

Market Cap.:
$5.66 million
Book Value:
Revenue TTM:
Operating Margin TTM:
Gross Profit TTM:
Profit Margin:
Return on Assets TTM:
Return on Equity TTM:

Company Profile

Aclarion Inc had its IPO on 2022-04-22 under the ticker symbol ACON.

The company operates in the Healthcare sector and Health Information Services industry. Aclarion Inc has a staff strength of 7 employees.

Stock update

Shares of Aclarion Inc opened at $0.38 at the start of the last trading session i.e. 2023-09-12.

The stocks traded within a range of $0.36 - $0.42, and closed at $0.41.

This is a -2.38% slip from the previous day's closing price.

A total volume of 55,256 shares were traded at the close of the day’s session.

In the last one week, shares of Aclarion Inc have slipped by -15.11%.

Aclarion Inc's Key Ratios

Aclarion Inc has a market cap of $5.66 million, indicating a price to book ratio of 1.9069 and a price to sales ratio of 91.8187.

In the last 12-months Aclarion Inc’s revenue was $60444 with a gross profit of $-4854 and an EBITDA of $-5904895. The EBITDA ratio measures Aclarion Inc's overall financial performance and is widely used to measure its profitability.

In the trailing 12-month period, Aclarion Inc’s operating margin was -10089.53% while its return on assets stood at -149.61% with a return of equity of 0%.

In Q4, Aclarion Inc’s quarterly earnings growth was a positive 0% while revenue growth was a positive 88%.

Aclarion Inc’s PE and PEG Ratio

Forward PE
Trailing PE

Its diluted EPS in the last 12-months stands at $-1.29 per share while it has a forward price to earnings multiple of 0 and a PEG multiple of . A low price to earnings ratio can mean the stock is attractively valued while a high ratio suggests the stock may be overvalued.

The PEG on the other hand provides a broader view compared to the P/E ratio and gives greater insight into Aclarion Inc’s profitability.

Aclarion Inc stock is trading at a EV to sales ratio of 151.1428 and a EV to EBITDA ratio of -1.3902. Its price to sales ratio in the trailing 12-months stood at 91.8187.

Aclarion Inc stock pays annual dividends of $0 per share, indicating a yield of 0% and a payout ratio of 0%.

Balance sheet and cash flow metrics

Total Assets
$3.21 million
Total Liabilities
$1.42 million
Operating Cash Flow
Capital Expenditure
Dividend Payout Ratio

Aclarion Inc ended 2024 with $3.21 million in total assets and $0 in total liabilities. Its intangible assets were valued at $3.21 million while shareholder equity stood at $1.79 million.

Aclarion Inc ended 2024 with $0 in deferred long-term liabilities, $1.42 million in other current liabilities, 79.00 in common stock, $-39907101.00 in retained earnings and $0 in goodwill. Its cash balance stood at $1.47 million and cash and short-term investments were $1.47 million. The company’s total short-term debt was $0 while long-term debt stood at $0.

Aclarion Inc’s total current assets stands at $1.99 million while long-term investments were $0 and short-term investments were $0. Its net receivables were $18569.00 compared to accounts payable of $457558.00 and inventory worth $0.

In 2024, Aclarion Inc's operating cash flow was $0 while its capital expenditure stood at $48248.

Comparatively, Aclarion Inc paid $0 in dividends in 2024.

Other key metrics

Current Trading Price
52-Week High
52-Week Low
Analyst Target Price

Aclarion Inc stock is currently trading at $0.41 per share. It touched a 52-week high of $4.35 and a 52-week low of $4.35. Analysts tracking the stock have a 12-month average target price of $3.

Its 50-day moving average was $0.56 and 200-day moving average was $0.7 The short ratio stood at 1.66 indicating a short percent outstanding of 0%.

Around 5935.9% of the company’s stock are held by insiders while 122.4% are held by institutions.

Frequently Asked Questions About Aclarion Inc

The stock symbol (also called stock or share ticker) of Aclarion Inc is ACON

The IPO of Aclarion Inc took place on 2022-04-22

Similar Industry Stocks (Health Information Services)

Last Price
Daseke Inc (DSKE)

Most Active

Last Price
Amyris Inc (AMRS)
Humbl Inc (HMBL)

Top Gainers

Last Price
Latch Inc (LTCHW)

Top Losers

Last Price


Aclarion, Inc., a healthcare technology company, develops software application for magnetic resonance spectroscopy (MRS) in the United States. It offers NOCISCAN-LS Post-Processor suite comprising NOCICALC-LS that receives and processes the acquired disc MRS data to calculate levels of degenerative pain biomarkers; and NOCIGRAM-LS, a clinical decision support software. The company was formerly known as Nocimed, Inc. and changed its name to Aclarion, Inc. in December 2021. Aclarion, Inc. was founded in 2008 and is based in San Mateo, California.


951 Mariners Island Boulevard, San Mateo, CA, United States, 94404